AI-generated summary
The authors report an uncontrolled trial of ablative erbium:YAG laser treatment in 20 men with chronic inflammatory non-cicatricial balanitis or balanoposthitis. Complete clearance was reported in all patients during follow-up of 3 to 30 months, with low pain scores and no severe adverse effects. The lack of a control group limits how strongly these results can be interpreted.
- Participants
- 20
- Who or what was studied
- 20 Caucasian male patients (mean age 64.8 years) with chronic inflammatory non-cicatricial balanitis or balanoposthitis
- Limits stated in the abstract
- The trial was uncontrolled, and the abstract reports a small sample followed for a mean of about 12 months.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on tandfonline.com.
Record from PubMed, a service of the National Library of Medicine.
Light parameters mentioned
Found in the title and abstract by pattern. They may be incomplete, so check the paper before comparing studies.
- Total energy
- 20 J
How to read a single study: what to check before relying on this kind of research.
Terms in this paper: Laser, Visual analogue scale, Fluence. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.